Decrease of SIRT3 in failing hearts from patients with obesity and metabolic syndrome leads to CypD hyperacetylation, mitochondrial permeability transition pore opening, and cardiac dysfunction.431. This evidence concerns the gene SIRT3 and metabolic syndrome.